Mode
Text Size
Log in / Sign up
N/A Completed N=1,431 Randomized Prevention

Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)

Source: ClinicalTrials.gov NCT03171545 ↗
Enrolled (actual)
1,431
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcomePrimary: Dialysis Session Stability — 0.202; 0.199; 0.172; 0.182 Proportion of sessions

Summary

The purpose of this study is reduce episodes of intradialytic hypotension, low blood pressure during a hemodialysis session, in patients with End Stage Renal Disease (ESRD). Recruitment will take place on the clinic level rather than the patient level.

Outcome Measures

OutcomeResultp-value
PRIMARY
Dialysis Session Stability
0.202; 0.199; 0.172; 0.182
SECONDARY
Fluid Adherence
2.12; 2.18; 2.35; 2.34
SECONDARY
Dialysis Adherence - Average Weekly Minutes Missed Over Intervention Period
5.23; 4.21; 5.28; 4.89
SECONDARY
Dialysis Adherence - Average Weekly Sessions Missed During Intervention Period
0.004; 0.008; 0.028; 0.032
SECONDARY
Patient Symptoms - Post-dialysis Recovery Time
0.141; 0.181; 0.178; 0.158
SECONDARY
Patient Symptoms - Symptom Burden
0.045; 0.069; 0.051; 0.063
SECONDARY
Quality of Life-KDQOL - MCS
53.85; 52.62; 54.58; 54.89
SECONDARY
Quality of Life-KDQOL - PCS
35.98; 38.01; 39.49; 36.18
SECONDARY
Hospitalization
1.55; 1.15; 1.37; 1.23
SECONDARY
Mortality
16.99; 9.30; 14.85; 10.44

Eligibility Criteria

Selection is at both the clinic level and individual patient level.

Clinic Inclusion Criteria:

  • outpatient hemodialysis facilities
  • at least 70 adult (>21 years old) patients to guarantee sample size

Clinic Exclusion Criteria:

  • facilities involved in another study
  • facilities in immediate jeopardy
  • facilities with 1-star quality ratings
  • facilities designated as COVID-19 isolation facilities

Individual Patient Exclusion Criteria:

  • individual patients who are currently incarcerated
  • individual patients who have poor cognition or cognitive impairment
  • individual patients unable to comprehend the patient information sheet due to lack of facility in English or Spanish
  • individual patients who have opted out of data collection
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03171545). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search